Lidds AB
LIDDS AB (publ), a drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden. Its product pipeline comprises Nanoimod, a NanoZolid-formulated agatolimod, as well as a toll-like receptor 9 (TLR9) agonist, which is in preclinical trial; Nanodotax, a NanoZolid-formulated docetaxel, which is a chemoth… Read more
Lidds AB (LIDDS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.413x
Based on the latest financial reports, Lidds AB (LIDDS) has a cash flow conversion efficiency ratio of -0.413x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-616.00K) by net assets (Skr1.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lidds AB - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Lidds AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lidds AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lidds AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SKANSKA -B- - Dusseldorf Stock Exchang
DU:SKNB
|
0.117x |
|
Generation Income Properties Inc Warrant
NASDAQ:GIPRW
|
0.032x |
|
KOPPERS HLDGS
BE:KO9
|
0.053x |
|
C WorldWide Stabile Aktier KL A
CO:CWISAKTKLA
|
N/A |
|
Sprott Physical Silver
TO:PSLV
|
0.006x |
|
Latitude Tree Holdings Bhd
KLSE:7006
|
0.021x |
|
WaterBridge Infrastructure LLC
NYSE:WBI
|
N/A |
|
Jyske In Fjernøsten Akt SRI KL
CO:JYIFJASRIKL
|
N/A |
Annual Cash Flow Conversion Efficiency for Lidds AB (2013–2024)
The table below shows the annual cash flow conversion efficiency of Lidds AB from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr6.18 Million | Skr-5.43 Million | -0.879x | +53.39% |
| 2023-12-31 | Skr13.90 Million | Skr-26.22 Million | -1.886x | +18.65% |
| 2022-12-31 | Skr15.35 Million | Skr-35.59 Million | -2.319x | -163.81% |
| 2021-12-31 | Skr48.51 Million | Skr-42.64 Million | -0.879x | -37.23% |
| 2020-12-31 | Skr42.81 Million | Skr-27.42 Million | -0.641x | -470.12% |
| 2019-12-31 | Skr152.13 Million | Skr-17.09 Million | -0.112x | -1131.42% |
| 2018-12-31 | Skr158.52 Million | Skr-1.45 Million | -0.009x | +89.16% |
| 2017-12-31 | Skr127.25 Million | Skr-10.71 Million | -0.084x | -352.72% |
| 2016-12-31 | Skr112.52 Million | Skr-2.09 Million | -0.019x | +74.68% |
| 2015-12-31 | Skr99.77 Million | Skr-7.33 Million | -0.073x | -3.47% |
| 2014-12-31 | Skr96.37 Million | Skr-6.84 Million | -0.071x | -1.37% |
| 2013-12-31 | Skr75.21 Million | Skr-5.27 Million | -0.070x | -- |